-
Why Is Cara Therapeutics Stock Trading Higher Today?
Tuesday, August 24, 2021 - 10:57am | 196Read More...Cara Therapeutics Inc (NASDAQ: CARA) is trading higher Tuesday after the company, and Vifor Pharma, announced the U.S. Food and Drug Administration approved KORSUVA for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults...
-
Cara Therapeutics' 15% Surge, Explained
Tuesday, March 28, 2017 - 8:58am | 542Read More...Shares of Cara Therapeutics Inc (NASDAQ: CARA), a small-cap clinical-stage bio-pharmaceutical company that develops therapies to alleviate pain, gained more than 15 percent early Tuesday morning after the company announced encouraging results from Part A of a Phase 2/3 trial. Cara has been...
-
Cara Therapeutics Gains 9% After The FDA Removed A Clinical Hold On An Ongoing Trial
Wednesday, April 20, 2016 - 9:38am | 303Read More...Shares of Cara Therapeutics Inc (NASDAQ: CARA) were trading higher by more than 9 percent early Wednesday morning after the company confirmed the U.S. Food and Drug Administration (FDA) removed a hold on a clinical trial. Cara Therapeutics said it received notice from the FDA that the agency...
-
FDA Places Cara Therapeutics' Pain Trial On Clinical Hold, Shares Plunge 42%
Friday, February 26, 2016 - 8:35am | 237Read More...Cara Therapeutics Inc (NASDAQ: CARA), a clinical-stage bio-pharmaceutical company that focuses on the development of chemical entities to alleviate pain and pruritus, announced a business update after Thursday's market close. Cara Therapeutics said that the U.S. Food and Drug Administration has...
